Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001023331 | SCV001185192 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001023331 | SCV001353582 | likely benign | Hereditary cancer-predisposing syndrome | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003743634 | SCV001679607 | likely benign | Familial adenomatous polyposis 1 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000204525 | SCV001886808 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000204525 | SCV002047137 | likely benign | not provided | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003897454 | SCV004712290 | likely benign | APC-related condition | 2020-09-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |